Parameters | No. | Mean | Mean-1.96 SD to mean + 1.96 SD | Median | 2.5 percentile to 97.5 percentile | CV |
---|---|---|---|---|---|---|
CD3+ T cells (%) | 601 | 68.03 | 53.86-82.19 | 68.52 | 53.33-81.22 | 0.106 |
CD3+ T cells (/μL) | 498 | 1494 | 754.8-2233 | 1464 | 876.8-2310 | 0.252 |
CD3-CD19+ B cells (%) | 784 | 11.19 | 4.575-17.81 | 11.01 | 5.389-18.23 | 0.301 |
CD3-CD19+ B cells (/μL) | 657 | 219.3 | 60.05-378.5 | 206 | 95.90-412.1 | 0.37 |
CD3+CD4+ T cells (%) a | 635 | 36.55 | 24.05-49.04 | 36.66 | 24.01-49.05 | 0.174 |
CD3+CD4+ T cells (/μL) | 355 | 782.5 | 374.6-1190 | 752 | 455.7-1261 | 0.265 |
CD3+CD8+ T cells (%) | 634 | 25.81 | 14.53-37.09 | 25.4 | 15.71-38.24 | 0.223 |
CD3+CD8+ T cells (/μL) | 753 | 522.9 | 163.4-882.4 | 491 | 258.9-958.7 | 0.351 |
CD3-CD16+CD56+ NK cells (%) | 664 | 18.88 | 4.554-33.21 | 18.37 | 6.369-34.83 | 0.387 |
CD3-CD16+CD56+ NK cells (/μL) | 414 | 376.1 | 34.47-717.7 | 346 | 109.8-780.4 | 0.463 |
CD28+CD4+ T cells (%) | 996 | 95.92 | 88.73-103.1 | 97 | 86.53-99.90 | 0.382 |
CD28+CD8+ T cells (%) a | 761 | 61.03 | 35.37-86.68 | 61.1 | 35.51-85.57 | 0.214 |
CD45RA+CD4+ T cells (%) a | 515 | 41.74 | 21.61-61.86 | 41.8 | 21.47-60.70 | 0.246 |
HLA-DR+CD8+ T cells (%) a | 423 | 39.42 | 13.49-65.35 | 38.29 | 17.36-64.08 | 0.335 |
IFN-γ+CD4+ T cells after stimulation (%) | 396 | 19.79 | 7.081-32.49 | 18.15 | 11.50-36.96 | 0.327 |
IFN-γ+CD8+ T cells after stimulation (%) a | 405 | 49.39 | 21.96-76.81 | 49.6 | 24.88-78.87 | 0.283 |